ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998

In Brief: NCI May Support Studies Of Heat As Therapeutic Method DTIC OK Near for Malignant Melanoma

May 16, 1975

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981